LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 24

Search options

  1. Article ; Online: Development of a Mechanism-Based Next-Generation Therapeutic for Heart Failure Derived From the Dark Genome.

    Viereck, Janika / Thum, Thomas

    JACC. Basic to translational science

    2023  Volume 8, Issue 12, Page(s) 1595–1598

    Abstract: The ability of nucleic acids for intramolecular interactions opens manifold opportunities for novel medicines that have the potential to treat intractable human disorders, including heart disease. In this context, microRNAs have been identified as ... ...

    Abstract The ability of nucleic acids for intramolecular interactions opens manifold opportunities for novel medicines that have the potential to treat intractable human disorders, including heart disease. In this context, microRNAs have been identified as pleiotropic regulators of disease pathways and consequently as powerful therapeutic targets. With antisense oligonucleotides novel drug modalities are available to specifically inhibit as well as correct derailed microRNAs including pathological downstream pathways potentially restoring hallmarks of disease. However, only a handful of microRNA-targeting drugs underwent clinical testing so far, and none in the cardiovascular field. In this paper, the authors introduce the first-ever microRNA-based therapy that entered clinical trials in heart disease and present the previous development from target identification to first-in-human studies.
    Language English
    Publishing date 2023-12-26
    Publishing country United States
    Document type Journal Article
    ISSN 2452-302X
    ISSN (online) 2452-302X
    DOI 10.1016/j.jacbts.2023.09.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Circulating Noncoding RNAs as Biomarkers of Cardiovascular Disease and Injury.

    Viereck, Janika / Thum, Thomas

    Circulation research

    2017  Volume 120, Issue 2, Page(s) 381–399

    Abstract: The discovery of thousands of noncoding RNAs (ncRNAs) has expanded our view on mammalian genomes and transcriptomes, as well as their organization and regulation. Accumulating evidence on aberrantly regulated ncRNAs, including short microRNAs, long ... ...

    Abstract The discovery of thousands of noncoding RNAs (ncRNAs) has expanded our view on mammalian genomes and transcriptomes, as well as their organization and regulation. Accumulating evidence on aberrantly regulated ncRNAs, including short microRNAs, long ncRNAs and circular RNAs, across various heart diseases indicates that ncRNAs are critical contributors to cardiovascular pathophysiology. In addition, ncRNAs are released into the circulation where they are present in concentration levels that differ between healthy subjects and diseased patients. Although little is known about the origin and function of such circulating ncRNAs, these molecules are increasingly recognized as noninvasive and readily accessible biomarker for risk stratification, diagnosis and prognosis of cardiac injury, and multiple forms of cardiovascular disease. In this review, we summarize recent findings on biological characteristics of circulating ncRNAs and highlight their value as potential biomarker in selected pathologies of cardiovascular disease.
    MeSH term(s) Animals ; Biomarkers/blood ; Cardiovascular Diseases/blood ; Cardiovascular Diseases/diagnosis ; Cardiovascular Diseases/genetics ; Humans ; MicroRNAs/blood ; MicroRNAs/genetics ; RNA, Long Noncoding/blood ; RNA, Long Noncoding/genetics ; RNA, Untranslated/blood ; RNA, Untranslated/genetics
    Chemical Substances Biomarkers ; MicroRNAs ; RNA, Long Noncoding ; RNA, Untranslated
    Language English
    Publishing date 2017-01-20
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 80100-8
    ISSN 1524-4571 ; 0009-7330 ; 0931-6876
    ISSN (online) 1524-4571
    ISSN 0009-7330 ; 0931-6876
    DOI 10.1161/CIRCRESAHA.116.308434
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Long Noncoding RNAs in Pathological Cardiac Remodeling.

    Viereck, Janika / Thum, Thomas

    Circulation research

    2017  Volume 120, Issue 2, Page(s) 262–264

    Abstract: A novel long noncoding RNA Chaer acts as noncoding epigenetic regulator at the onset of cardiac hypertrophy and enables an improved understanding about the complex mechanisms in cardiovascular disease. ...

    Abstract A novel long noncoding RNA Chaer acts as noncoding epigenetic regulator at the onset of cardiac hypertrophy and enables an improved understanding about the complex mechanisms in cardiovascular disease.
    MeSH term(s) Animals ; Cardiomegaly/diagnosis ; Cardiomegaly/genetics ; Cardiomegaly/physiopathology ; Cardiovascular Diseases/diagnosis ; Cardiovascular Diseases/genetics ; Cardiovascular Diseases/physiopathology ; Humans ; RNA, Long Noncoding/genetics ; Ventricular Remodeling/genetics
    Chemical Substances RNA, Long Noncoding
    Language English
    Publishing date 2017-01-20
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 80100-8
    ISSN 1524-4571 ; 0009-7330 ; 0931-6876
    ISSN (online) 1524-4571
    ISSN 0009-7330 ; 0931-6876
    DOI 10.1161/CIRCRESAHA.116.310174
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Efficacy and safety of CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: Rationale and design of the HF-REVERT trial.

    Bauersachs, Johann / Solomon, Scott D / Anker, Stefan D / Antorrena-Miranda, Isabel / Batkai, Sandor / Viereck, Janika / Rump, Steffen / Filippatos, Gerasimos / Granzer, Ulrich / Ponikowski, Piotr / de Boer, Rudolf A / Vardeny, Orly / Hauke, Wilfried / Thum, Thomas

    European journal of heart failure

    2024  

    Abstract: Aim: Inhibition of microRNA (miR)-132 effectively prevents and reverses adverse cardiac remodelling, making it an attractive heart failure (HF) target. CDR132L, a synthetic antisense oligonucleotide selectively blocking pathologically elevated miR-132, ... ...

    Abstract Aim: Inhibition of microRNA (miR)-132 effectively prevents and reverses adverse cardiac remodelling, making it an attractive heart failure (HF) target. CDR132L, a synthetic antisense oligonucleotide selectively blocking pathologically elevated miR-132, demonstrated beneficial effects on left ventricular (LV) structure and function in relevant preclinical models, and was safe and well tolerated in a Phase 1b study in stable chronic HF patients. Patients with acute myocardial infarction (MI) and subsequent LV dysfunction and remodelling have limited therapeutic options, and may profit from early CDR132L treatment.
    Methods: The HF-REVERT (Phase 2, multicenter, randomized, parallel, 3-arm, placebo-controlled Study to Assess Efficacy and Safety of CDR132L in Patients with Reduced Left Ventricular Ejection Fraction after Myocardial Infarction) evaluates the efficacy and safety of CDR132L in HF patients post-acute MI (n = 280), comparing the effect of 5 and 10 mg/kg CDR132L, administered as three single intravenous doses 28 days apart, in addition to standard of care. Key inclusion criteria are the diagnosis of acute MI, the development of systolic dysfunction (LV ejection fraction ≤45%) and elevated N-terminal pro-B-type natriuretic peptide. The study consists of a 6-month double-blinded treatment period with the primary endpoint LV end-systolic volume index and relevant secondary endpoints, followed by a 6-month open-label observation period.
    Conclusion: The HF-REVERT trial may underpin the concept of miR-132 inhibition to prevent or reverse cardiac remodelling in post-MI HF. The results will inform the design of subsequent outcome trials to test CDR132L in HF.
    Language English
    Publishing date 2024-01-25
    Publishing country England
    Document type Journal Article
    ZDB-ID 1483672-5
    ISSN 1879-0844 ; 1388-9842
    ISSN (online) 1879-0844
    ISSN 1388-9842
    DOI 10.1002/ejhf.3139
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Structural and functional characterization of the Curli adaptor protein CsgF

    Schubeis, Tobias / Spehr, Johannes / Viereck, Janika / Köpping, Laura / Nagaraj, Madhu / Ahmed, Mumdooh / Ritter, Christiane

    FEBS letters. 2018 Mar., v. 592, no. 6

    2018  

    Abstract: Curli are functional amyloids that form a major part of the biofilm produced by many enterobacteriaceae. A multiprotein system around the outer membrane protein CsgG is in charge of the export and controlled propagation of the main Curli subunits, CsgA ... ...

    Abstract Curli are functional amyloids that form a major part of the biofilm produced by many enterobacteriaceae. A multiprotein system around the outer membrane protein CsgG is in charge of the export and controlled propagation of the main Curli subunits, CsgA and CsgB. CsgF is essential for the linkage of the main amyloid‐forming proteins to the cell surface. Here, we present a profound biochemical and biophysical characterization of recombinant CsgF, highlighted by a solution NMR structure of CsgF in the presence of dihexanoylphosphocholine micelles. Interestingly, CsgF contains large unstructured domains and does not show a globular fold. The data presented shed new light on the molecular mechanism of Curli amyloid surface attachment.
    Keywords Enterobacteriaceae ; amyloid ; biofilm ; exports ; micelles ; outer membrane proteins
    Language English
    Dates of publication 2018-03
    Size p. 1020-1029.
    Publishing place John Wiley & Sons, Ltd
    Document type Article
    Note LETTER
    ZDB-ID 212746-5
    ISSN 1873-3468 ; 0014-5793
    ISSN (online) 1873-3468
    ISSN 0014-5793
    DOI 10.1002/1873-3468.13002
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  6. Article ; Online: Long noncoding RNAs as inducers and terminators of vascular development.

    Viereck, Janika / Kumarswamy, Regalla / Thum, Thomas

    Circulation

    2015  Volume 131, Issue 14, Page(s) 1236–1238

    MeSH term(s) Animals ; Cardiovascular System/growth & development ; Endothelial Cells/chemistry ; Gene Expression Regulation, Developmental/genetics ; Humans ; Myocytes, Cardiac/chemistry ; Pluripotent Stem Cells/chemistry ; RNA, Long Noncoding/isolation & purification ; Vertebrates/genetics
    Chemical Substances RNA, Long Noncoding
    Language English
    Publishing date 2015-04-07
    Publishing country United States
    Document type Comment ; Editorial ; Research Support, Non-U.S. Gov't
    ZDB-ID 80099-5
    ISSN 1524-4539 ; 0009-7322 ; 0069-4193 ; 0065-8499
    ISSN (online) 1524-4539
    ISSN 0009-7322 ; 0069-4193 ; 0065-8499
    DOI 10.1161/CIRCULATIONAHA.115.015775
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: AAV capsid engineering identified two novel variants with improved in vivo tropism for cardiomyocytes.

    Rode, Laura / Bär, Christian / Groß, Sonja / Rossi, Axel / Meumann, Nadja / Viereck, Janika / Abbas, Naisam / Xiao, Ke / Riedel, Isabelle / Gietz, Anika / Zimmer, Karina / Odenthal, Margarete / Büning, Hildegard / Thum, Thomas

    Molecular therapy : the journal of the American Society of Gene Therapy

    2022  Volume 30, Issue 12, Page(s) 3601–3618

    Abstract: AAV vectors are promising delivery tools for human gene therapy. However, broad tissue tropism and pre-existing immunity against natural serotypes limit their clinical use. We identified two AAV capsid variants, AAV2-THGTPAD and AAV2-NLPGSGD, by in vivo ... ...

    Abstract AAV vectors are promising delivery tools for human gene therapy. However, broad tissue tropism and pre-existing immunity against natural serotypes limit their clinical use. We identified two AAV capsid variants, AAV2-THGTPAD and AAV2-NLPGSGD, by in vivo AAV2 peptide display library screening in a murine model of pressure overload-induced cardiac hypertrophy. Both variants showed significantly improved efficacy in in vivo cardiomyocyte transduction compared with the parental serotype AAV2 as indicated by a higher number of AAV vector episomes in the nucleus and significant improved transduction efficiency. Both variants also outcompeted the reference serotype AAV9 regarding cardiomyocyte tropism, reaching comparable cardiac transduction efficiencies accompanied with liver de-targeting and decreased transduction efficiency of non-cardiac cells. Capsid modification influenced immunogenicity as sera of mice treated with AAV2-THGTPAD and AAV2-NLPGSGD demonstrated a poor neutralization capacity for the parental serotype and the novel variants. In a therapeutic setting, using the long non-coding RNA H19 in low vector dose conditions, novel AAV variants mediated superior anti-hypertrophic effects and revealed a further improved target-to-noise ratio, i.e., cardiomyocyte tropism. In conclusion, AAV2-THGTPAD and AAV2-NLPGSGD are promising novel tools for cardiac-directed gene therapy outperforming AAV9 regarding the specificity and therapeutic efficiency of in vivo cardiomyocyte transduction.
    MeSH term(s) Animals ; Humans ; Mice ; RNA, Long Noncoding ; Myocytes, Cardiac ; Tropism ; Capsid
    Chemical Substances RNA, Long Noncoding
    Language English
    Publishing date 2022-07-09
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2010592-7
    ISSN 1525-0024 ; 1525-0016
    ISSN (online) 1525-0024
    ISSN 1525-0016
    DOI 10.1016/j.ymthe.2022.07.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: miR-21-KO Alleviates Alveolar Structural Remodeling and Inflammatory Signaling in Acute Lung Injury.

    Jansing, Johanna Christine / Fiedler, Jan / Pich, Andreas / Viereck, Janika / Thum, Thomas / Mühlfeld, Christian / Brandenberger, Christina

    International journal of molecular sciences

    2020  Volume 21, Issue 3

    Abstract: Acute lung injury (ALI) is characterized by enhanced permeability of the air-blood barrier, pulmonary edema, and hypoxemia. MicroRNA-21 (miR-21) was shown to be involved in pulmonary remodeling and the pathology of ALI, and we hypothesized that miR-21 ... ...

    Abstract Acute lung injury (ALI) is characterized by enhanced permeability of the air-blood barrier, pulmonary edema, and hypoxemia. MicroRNA-21 (miR-21) was shown to be involved in pulmonary remodeling and the pathology of ALI, and we hypothesized that miR-21 knock-out (KO) reduces injury and remodeling in ALI. ALI was induced in miR-21 KO and C57BL/6N (wildtype, WT) mice by an intranasal administration of 75 µg lipopolysaccharide (LPS) in saline (
    MeSH term(s) Acute Lung Injury/etiology ; Acute Lung Injury/metabolism ; Acute Lung Injury/pathology ; Acute Lung Injury/physiopathology ; Airway Remodeling/genetics ; Alveolar Epithelial Cells/metabolism ; Alveolar Epithelial Cells/ultrastructure ; Animals ; Chromatography, Liquid ; Cytokines/genetics ; Cytokines/metabolism ; Disease Models, Animal ; Disease Susceptibility ; Gene Expression Profiling ; Male ; Mass Spectrometry ; Mice ; Mice, Knockout ; MicroRNAs/genetics ; Pulmonary Alveoli/metabolism ; Pulmonary Alveoli/pathology ; Pulmonary Alveoli/ultrastructure ; RAW 264.7 Cells ; Respiratory Function Tests ; Signal Transduction
    Chemical Substances Cytokines ; MIRN21 microRNA, mouse ; MicroRNAs
    Language English
    Publishing date 2020-01-27
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms21030822
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Structural and functional characterization of the Curli adaptor protein CsgF.

    Schubeis, Tobias / Spehr, Johannes / Viereck, Janika / Köpping, Laura / Nagaraj, Madhu / Ahmed, Mumdooh / Ritter, Christiane

    FEBS letters

    2018  Volume 592, Issue 6, Page(s) 1020–1029

    Abstract: Curli are functional amyloids that form a major part of the biofilm produced by many enterobacteriaceae. A multiprotein system around the outer membrane protein CsgG is in charge of the export and controlled propagation of the main Curli subunits, CsgA ... ...

    Abstract Curli are functional amyloids that form a major part of the biofilm produced by many enterobacteriaceae. A multiprotein system around the outer membrane protein CsgG is in charge of the export and controlled propagation of the main Curli subunits, CsgA and CsgB. CsgF is essential for the linkage of the main amyloid-forming proteins to the cell surface. Here, we present a profound biochemical and biophysical characterization of recombinant CsgF, highlighted by a solution NMR structure of CsgF in the presence of dihexanoylphosphocholine micelles. Interestingly, CsgF contains large unstructured domains and does not show a globular fold. The data presented shed new light on the molecular mechanism of Curli amyloid surface attachment.
    MeSH term(s) Escherichia coli/chemistry ; Escherichia coli/genetics ; Escherichia coli Proteins/chemistry ; Escherichia coli Proteins/genetics ; Nuclear Magnetic Resonance, Biomolecular ; Protein Domains ; Protein Folding ; Recombinant Proteins/chemistry ; Recombinant Proteins/genetics
    Chemical Substances Escherichia coli Proteins ; Recombinant Proteins
    Language English
    Publishing date 2018-02-21
    Publishing country England
    Document type Letter ; Research Support, Non-U.S. Gov't
    ZDB-ID 212746-5
    ISSN 1873-3468 ; 0014-5793
    ISSN (online) 1873-3468
    ISSN 0014-5793
    DOI 10.1002/1873-3468.13002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches.

    Beermann, Julia / Piccoli, Maria-Teresa / Viereck, Janika / Thum, Thomas

    Physiological reviews

    2016  Volume 96, Issue 4, Page(s) 1297–1325

    Abstract: Advances in RNA-sequencing techniques have led to the discovery of thousands of non-coding transcripts with unknown function. There are several types of non-coding linear RNAs such as microRNAs (miRNA) and long non-coding RNAs (lncRNA), as well as ... ...

    Abstract Advances in RNA-sequencing techniques have led to the discovery of thousands of non-coding transcripts with unknown function. There are several types of non-coding linear RNAs such as microRNAs (miRNA) and long non-coding RNAs (lncRNA), as well as circular RNAs (circRNA) consisting of a closed continuous loop. This review guides the reader through important aspects of non-coding RNA biology. This includes their biogenesis, mode of actions, physiological function, as well as their role in the disease context (such as in cancer or the cardiovascular system). We specifically focus on non-coding RNAs as potential therapeutic targets and diagnostic biomarkers.
    MeSH term(s) Biomarkers/metabolism ; Humans ; MicroRNAs/physiology ; RNA/physiology ; RNA, Long Noncoding/physiology
    Chemical Substances Biomarkers ; MicroRNAs ; RNA, Long Noncoding ; RNA, circular ; RNA (63231-63-0)
    Language English
    Publishing date 2016
    Publishing country United States
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 209902-0
    ISSN 1522-1210 ; 0031-9333
    ISSN (online) 1522-1210
    ISSN 0031-9333
    DOI 10.1152/physrev.00041.2015
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top